-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk's NozeU® has been approved by the US FDA, making it the first and only long-term weekly growth hormone for children with Turner syndrome.

Zhitongcaijing·11/20/2026 16:57:10
Listen to the news
Novo Nordisk's NozeU® has been approved by the US FDA, making it the first and only long-term weekly growth hormone for children with Turner syndrome.